Christopher L Gaenzle insider trades: PRA Health Sciences (PRAH) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Christopher reports to the SEC
Open-market buys and sales
18 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 17, 2021 | PRAH | ↓ Sell | 27,497 | $168.67 | $4.6M | Direct | Jun 21, 2021 (4d) |
| Jun 16, 2021 | PRAH | ↓ Sell | 28,866 | $167.41 | $4.8M | Direct | Jun 17, 2021 (1d) |
| Jun 1, 2021 | PRAH | ↓ Sell | 850 | $170.45 | $145K | Direct | Jun 3, 2021 (2d) |
| Jan 8, 2021 | PRAH | ↓ Sell | 3,136 | $130.04 | $408K | Direct | Jan 11, 2021 (3d) |
| Aug 13, 2020 | PRAH | ↓ Sell | 1,364 | $102.88 | $140K | Direct | Aug 17, 2020 (4d) |
| Jan 22, 2018 | SYNH | ↓ Sell | 1,470 | $41.00 | $60K | Direct | Jan 23, 2018 (1d) |
| Sep 18, 2017 | INCR | ↓ Sell | 4,682 | $54.55 | $255K | Direct | Sep 19, 2017 (1d) |
| Sep 1, 2017 | INCR | ↓ Sell | 42,601 | $58.67 | $2.5M | Direct | Sep 5, 2017 (4d) |
| Jul 3, 2017 | INCR | ↓ Sell | 6,873 | $58.32 | $401K | Direct | Jul 5, 2017 (2d) |
| Apr 3, 2017 | INCR | ↓ Sell | 4,733 | $45.70 | $216K | Direct | Apr 4, 2017 (1d) |
| Jan 20, 2017 | INCR | ↓ Sell | 1,186 | $50.09 | $59K | Direct | Jan 23, 2017 (3d) |
| Jan 3, 2017 | INCR | ↓ Sell | 15,383 | $51.90 | $798K | Direct | Jan 4, 2017 (1d) |
| Sep 14, 2016 | INCR | ↓ Sell | 4,734 | $43.14 | $204K | Direct | Sep 16, 2016 (2d) |
| Jul 11, 2016 | INCR | ↓ Sell | 21,918 | $40.20 | $881K | Direct | Jul 12, 2016 (1d) |
| Jun 15, 2016 | INCR | ↓ Sell | 7,702 | $40.14 | $309K | Direct | Jun 16, 2016 (1d) |
| Dec 31, 2015 | INCR | ↓ Sell | 9,468 | $48.18 | $456K | Direct | Jan 4, 2016 (4d) |
| Dec 8, 2015 | INCR | ↓ Sell | 25,185 | $41.78 | $1.1M | Direct | Dec 9, 2015 (1d) |
| Aug 31, 2015 | INCR | ↓ Sell | 17,421 | $41.16 | $717K | Direct | Sep 1, 2015 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Christopher L Gaenzle's insider trades
Christopher L Gaenzle is EVP, CAO & General Counsel at PRA Health Sciences (PRAH). Since Aug 31, 2015, Christopher has reported no open-market purchases and 18 sales worth $18.1M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include option exercises (14 filings), grants and awards (7 filings), shares withheld for taxes (6 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PRAH insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.